Introduction to CEUS for Abdominal Applications: watch here
Introduction to CEUS for Echocardiography: watch here
Special thanks to ICUS Board Member Bev Gorman, the Intersocietal Accreditation Commission, and speakers Cyndi Peterson and Pam Burgess.
Ultrasound can provide a safe and reliable imaging option for Covid-19 patients, and the addition of an ultrasound enhancing agent may be essential for evaluating heart and lung function.
CLICK HERE to find protocols for protecting personnel, disinfecting equipment, safely administering ultrasound contrast or enhancing agents, and appropriately imaging these highly vulnerable patients. Additional submissions may be sent to info@icus-society.org
ICUS supports the global ultrasound community during this rapidly evolving global crisis and extends heartfelt wishes for your safety and health as we come together to defeat this deadly virus.
The ICUS Bubble Blog showcases real-life CEUS experiences from around the world, with a special focus on how CEUS impacts individual patients and their care.
By Dr. Arezu Monawer
Resident, Department of Radiology, University of Washington, Seattle, WA
Mr. Y is a 56-year-old father of two. During a recent routine visit to his doctor, he said he felt good and appeared to be healthy.
Unfortunately, a digital rectal exam proved to be abnormal and Mr. Y’s prostate specific antigen blood count was elevated. A subsequent biopsy showed signs of prostate cancer.
To evaluate the size of Mr. Y’s prostate cancer and how far it may have spread, he underwent a bone scan and a pelvic MRI. Fortunately, the bone scan demonstrated no metastatic lesions in his skeleton. However, the pelvic MRI showed that two lymph nodes were slightly enlarged.
